Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-06843195

🥰Excellent
Catalog No. T36308Cas No. 2067281-51-8
Alias PF06843195

PF-06843195 is a potent and selective PI3Kα inhibitor that binds to the active site of PI3Kα and prevents it from catalyzing the conversion of PIP2 to PIP3, thereby inhibiting the activation of AKT, with anti-tumor activity in vitro and in vivo.

PF-06843195

PF-06843195

🥰Excellent
Purity: 98.01%
Catalog No. T36308Alias PF06843195Cas No. 2067281-51-8
PF-06843195 is a potent and selective PI3Kα inhibitor that binds to the active site of PI3Kα and prevents it from catalyzing the conversion of PIP2 to PIP3, thereby inhibiting the activation of AKT, with anti-tumor activity in vitro and in vivo.
Pack SizePriceAvailabilityQuantity
2 mg$239 In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:98.01%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PF-06843195 is a potent and selective PI3Kα inhibitor that binds to the active site of PI3Kα and prevents it from catalyzing the conversion of PIP2 to PIP3, thereby inhibiting the activation of AKT, with anti-tumor activity in vitro and in vivo.
Targets&IC50
PI3Kδ:0.28 nM (Ki), PI3Kδ:160 nM (IC50, in Rat1 fibroblasts), PI3Kα:0.018 nM (Ki)
In vitro
PF-06843195 is able to inhibit the proliferation of T47D and MCF7 cells with IC50 values ​​of 32 nM and 62 nM, respectively. [1]
In vivo
Methods: PF-06843195 (10 mg/kg, oral) and (2 mg/kg, intravenous) were used to treat rats and study its pharmacokinetics.
Results: It showed excellent bioavailability (25%) after oral administration and high plasma clearance (30 mL/min/kg) and large distribution volume (3.0 L/kg) after intravenous injection. [1]
AliasPF06843195
Chemical Properties
Molecular Weight498.46
FormulaC20H25F3N8O4
Cas No.2067281-51-8
SmilesN([C@]1(CO)CN(C(OCC(F)F)=O)CC1)C=2C(F)=C(N=C(N2)N3CCOCC3)C=4C=NC(N)=NC4
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50.00 mg/mL (100.31 mM), Sonication and heating are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0062 mL10.0309 mL20.0618 mL100.3090 mL
5 mM0.4012 mL2.0062 mL4.0124 mL20.0618 mL
10 mM0.2006 mL1.0031 mL2.0062 mL10.0309 mL
20 mM0.1003 mL0.5015 mL1.0031 mL5.0154 mL
50 mM0.0401 mL0.2006 mL0.4012 mL2.0062 mL
100 mM0.0201 mL0.1003 mL0.2006 mL1.0031 mL

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-06843195 | purchase PF-06843195 | PF-06843195 cost | order PF-06843195 | PF-06843195 chemical structure | PF-06843195 in vivo | PF-06843195 in vitro | PF-06843195 formula | PF-06843195 molecular weight